id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0661-0008,FDA,FDA-2010-E-0661,Letter from U.S. Patent and Trademark Office to Ssanofi-avetis U.S. Inc.,Other,Letter(s),2014-04-04T04:00:00Z,2014,4,2014-04-04T04:00:00Z,,2014-04-04T19:34:42Z,,0,0,090000648169f040
FDA-2010-E-0661-0007,FDA,FDA-2010-E-0661,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T19:42:58Z,,0,0,090000648119ca07
FDA-2010-E-0661-0005,FDA,FDA-2010-E-0661,Regulatory Review Period for Purposes of Patent Extension: JEVTANA,Notice,General Notice,2012-05-04T04:00:00Z,2012,5,2012-05-04T04:00:00Z,2012-07-04T03:59:59Z,2012-05-14T12:01:54Z,2012-10828,0,0,0900006481005090
FDA-2010-E-0661-0004,FDA,FDA-2010-E-0661,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-04-18T04:00:00Z,2012,4,2012-04-18T04:00:00Z,,2012-04-18T14:35:36Z,,0,0,0900006480ff3960
FDA-2010-E-0661-0003,FDA,FDA-2010-E-0661,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,Letter(s),2012-01-10T05:00:00Z,2012,1,2012-01-10T05:00:00Z,,2012-01-10T15:27:43Z,,0,0,0900006480f91f3c
FDA-2010-E-0661-0002,FDA,FDA-2010-E-0661,U.S. Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-07-27T23:41:23Z,,0,0,0900006480bc2a28
FDA-2010-E-0661-0001,FDA,FDA-2010-E-0661,Aventis Pharma S.A. - Patent Term Extension Application,Other,APP-Application,2010-12-30T05:00:00Z,2010,12,2010-12-30T05:00:00Z,,2013-07-27T23:41:23Z,,0,0,0900006480bc2a24